Predictive Oncology Inc. (NASDAQ:POAI – Get Free Report) shares crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $3.13 and traded as low as $2.57. Predictive Oncology shares last traded at $2.78, with a volume of 9,915 shares trading hands.
Predictive Oncology Trading Down 8.3 %
The firm has a market cap of $10.35 million, a P/E ratio of -0.55 and a beta of 1.30. The company’s 50-day moving average is $2.99 and its two-hundred day moving average is $3.13.
Institutional Investors Weigh In On Predictive Oncology
A number of hedge funds have recently modified their holdings of the stock. Renaissance Technologies LLC raised its holdings in Predictive Oncology by 2,582.8% during the 2nd quarter. Renaissance Technologies LLC now owns 405,100 shares of the medical instruments supplier’s stock valued at $166,000 after acquiring an additional 390,000 shares during the period. Citadel Advisors LLC purchased a new stake in shares of Predictive Oncology during the third quarter worth about $65,000. Raymond James & Associates bought a new position in Predictive Oncology in the third quarter worth about $378,000. Virtu Financial LLC bought a new position in Predictive Oncology in the fourth quarter worth about $25,000. Finally, Charles Schwab Investment Management Inc. bought a new position in shares of Predictive Oncology during the first quarter valued at approximately $54,000. Institutional investors own 9.04% of the company’s stock.
Predictive Oncology Company Profile
Predictive Oncology Inc operates as a science-driven company on the oncology drug discovery. It provides various solutions for the oncology drug development. The company, through the integration of scientific rigor and machine learning, has developed the ability to advance molecules into medicine by introducing human diversity earlier into the discovery process with the pairing of artificial intelligence and the biobank of approximately 150K tumor samples.
Recommended Stories
- Five stocks we like better than Predictive Oncology
- How to Buy Cheap Stocks Step by Step
- 3 Value Stocks Too Small For Buffett’s Portfolio
- When to Sell a Stock for Profit or Loss
- Foot Locker Builds Up Another Head of Steam; Gains Imminent
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Disney Stock Catches 3 Upgrades In a Single Week
Receive News & Ratings for Predictive Oncology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Predictive Oncology and related companies with MarketBeat.com's FREE daily email newsletter.
